Pancreatic cancer and Targeted therapy

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Pancreatic cancer and Targeted therapy

Pancreatic cancer vs. Targeted therapy

Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. Targeted therapy or molecularly targeted therapy is one of the major modalities of medical treatment (pharmacotherapy) for cancer, others being hormonal therapy and cytotoxic chemotherapy.

Breast cancer

Breast cancer is cancer that develops from breast tissue.

Breast cancer and Pancreatic cancer · Breast cancer and Targeted therapy · See more »

Cancer

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.

Cancer and Pancreatic cancer · Cancer and Targeted therapy · See more »

Cancer stem cell

Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.

Cancer stem cell and Pancreatic cancer · Cancer stem cell and Targeted therapy · See more »

Chemotherapy

Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen.

Chemotherapy and Pancreatic cancer · Chemotherapy and Targeted therapy · See more »

Clinical trial

Clinical trials are experiments or observations done in clinical research.

Clinical trial and Pancreatic cancer · Clinical trial and Targeted therapy · See more »

Colorectal cancer

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).

Colorectal cancer and Pancreatic cancer · Colorectal cancer and Targeted therapy · See more »

Cytotoxicity

Cytotoxicity is the quality of being toxic to cells.

Cytotoxicity and Pancreatic cancer · Cytotoxicity and Targeted therapy · See more »

Erlotinib

Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer.

Erlotinib and Pancreatic cancer · Erlotinib and Targeted therapy · See more »

Everolimus

No description.

Everolimus and Pancreatic cancer · Everolimus and Targeted therapy · See more »

Immunotherapy

Immunotherapy is the "treatment of disease by inducing, enhancing, or suppressing an immune response".

Immunotherapy and Pancreatic cancer · Immunotherapy and Targeted therapy · See more »

Lung cancer

Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung.

Lung cancer and Pancreatic cancer · Lung cancer and Targeted therapy · See more »

Melanoma

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes.

Melanoma and Pancreatic cancer · Melanoma and Targeted therapy · See more »

Neoplasm

Neoplasia is a type of abnormal and excessive growth of tissue.

Neoplasm and Pancreatic cancer · Neoplasm and Targeted therapy · See more »

Prostate cancer

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.

Pancreatic cancer and Prostate cancer · Prostate cancer and Targeted therapy · See more »

Sunitinib

Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006.

Pancreatic cancer and Sunitinib · Sunitinib and Targeted therapy · See more »